Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Receivables (2023 - 2025)

Historic Change in Receivables for CervoMed (CRVO) over the last 4 years, with Q3 2025 value amounting to -$999588.0.

  • CervoMed's Change in Receivables fell 47841.97% to -$999588.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 31538.8%. This contributed to the annual value of $1.3 million for FY2024, which is 4625.53% up from last year.
  • Per CervoMed's latest filing, its Change in Receivables stood at -$999588.0 for Q3 2025, which was down 47841.97% from $731748.0 recorded in Q2 2025.
  • In the past 5 years, CervoMed's Change in Receivables ranged from a high of $2.0 million in Q4 2024 and a low of -$999588.0 during Q3 2025
  • Moreover, its 3-year median value for Change in Receivables was $264148.0 (2024), whereas its average is $194483.9.
  • In the last 5 years, CervoMed's Change in Receivables surged by 11739.94% in 2024 and then plummeted by 47841.97% in 2025.
  • CervoMed's Change in Receivables (Quarter) stood at $915404.0 in 2023, then surged by 117.4% to $2.0 million in 2024, then crashed by 150.23% to -$999588.0 in 2025.
  • Its Change in Receivables was -$999588.0 in Q3 2025, compared to $731748.0 in Q2 2025 and -$625004.0 in Q1 2025.